Drug Profile
Research programme: neurotoxin based therapeutics - Toxcure
Alternative Names: botulinum - ToxcureLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Toxcure
- Class Bacterial toxins
- Mechanism of Action Acetylcholine inhibitors; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in USA
- 21 May 2010 Preclinical trials in Solid tumours in USA (unspecified route)